| Name | Title | Contact Details |
|---|
BL Software Systems/BL Healthcare is a Foxborough, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Fountain Life brings together the world’s most renowned medical and health experts to boost longevity and performance. Our goal is to educate our members and empower them to be proactive about their health. We help our members operate at peak performan...
Pointe Scientific Inc. is a Canton, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Mosaic is a whole-person healthcare organization reaching across 11 states and providing supports to more than 4,500 people. Services empower people with disabilities, mental and behavioral health needs and autism, as well as aging adults to live their best life. Mosaic is an affiliated social ministry organization of the Evangelical Lutheran Church in America and a member of Lutheran Services in America. Mosaic is a nonprofit 501(c)(3) organization.
Bionor Pharma is a leading biotechnology company advancing the first therapeutic vaccine towards a functional cure for HIV. The company`s focus is the research and development of peptide-based vaccines against viral diseases, primarily HIV. Bionor Pharma`s most advanced product candidate is Vacc-4x, which is also the most advanced therapeutic vaccine in the HIV space and has demonstrated a reduction of viral load in a large, randomized, controlled Phase II trial, as well as safety and tolerability. Pharma`s current clinical focus is to explore whether Vacc-4x, used with other medicines as a combination therapy, can reduce the viral load even further, and the company, through collaboration with Celgene, is investigating Vacc-4x and the HDAC inhibitor romidepsin in the REDUC study. In May 2015, Bionor Pharma announced promising results from an interim analysis of Part B of the REDUC study. In the study, Vacc-4x and romidepsin are explored as a possible treatment regimen to reduce the persistent latent viral reservoir in HIV infected patients on anti-retroviral treatment. Results are expected in the second half of 2015. Bionor Pharma is headquartered in Oslo, Norway, with offices in Copenhagen and New York.